Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sundar, S
   Drug resistance in Indian visceral leishmaniasis
   TROPICAL MEDICINE & INTERNATIONAL HEALTH
   
   S. Sundar, "Drug resistance in Indian visceral leishmaniasis", TR MED I H, 6(11), 2001, pp. 849-854
2. Croft, SL
   Monitoring drug resistance in leishmaniasis
   TROPICAL MEDICINE & INTERNATIONAL HEALTH
   
   S.L. Croft, "Monitoring drug resistance in leishmaniasis", TR MED I H, 6(11), 2001, pp. 899-905
3. Bryceson, A
   A policy for leishmaniasis with respect to the prevention and control of drug resistance
   TROPICAL MEDICINE & INTERNATIONAL HEALTH
   
   A. Bryceson, "A policy for leishmaniasis with respect to the prevention and control of drug resistance", TR MED I H, 6(11), 2001, pp. 928-934
4. Thakur, CP; Ahmed, S
   Observations on amphotericin B treatment of kala-azar given in a rural setup in Bihar, India
   INDIAN JOURNAL OF MEDICAL RESEARCH
   
   C.P. Thakur e S. Ahmed, "Observations on amphotericin B treatment of kala-azar given in a rural setup in Bihar, India", I J MED RES, 113, 2001, pp. 14-18
5. Teixiera, MJ; de Almeida, YM; Viana, JR; Holanda, JG; Rodrigues, TP; Prata, JRC; Coelho, IVB; Rao, VS; Pompeu, MML
   In vitro and in vivo leishmanicidal activity of 2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone (lapachol)
   PHYTOTHERAPY RESEARCH
   
   M.J. Teixiera et al., "In vitro and in vivo leishmanicidal activity of 2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone (lapachol)", PHYTOTHER R, 15(1), 2001, pp. 44-48
6. Thakur, CP
   A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study
   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
   
   C.P. Thakur, "A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study", INT J ANT A, 17(1), 2001, pp. 67-70
7. Kuyucu, N; Kara, C; Bakirtac, A; Tezic, T
   Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate
   PEDIATRIC INFECTIOUS DISEASE JOURNAL
   
   N. Kuyucu et al., "Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate", PEDIAT INF, 20(4), 2001, pp. 455-457
8. Haidar, NA; Diab, ABL; El-Sheikh, AM
   Visceral leishmaniasis in children in the Yemen
   SAUDI MEDICAL JOURNAL
   
   N.A. Haidar et al., "Visceral leishmaniasis in children in the Yemen", SAUDI MED J, 22(6), 2001, pp. 516-519
9. Palmer, RA; Tran, D; Hepburn, NC; Ashton, RE
   The management of cutaneous leishmaniasis from Belize
   CLINICAL AND EXPERIMENTAL DERMATOLOGY
   
   R.A. Palmer et al., "The management of cutaneous leishmaniasis from Belize", CLIN EXP D, 26(1), 2001, pp. 16-20
10. Bryceson, A
    Current issues in the treatment of visceral leishmaniasis
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY
    
    A. Bryceson, "Current issues in the treatment of visceral leishmaniasis", MED MICROBI, 190(1-2), 2001, pp. 81-84
11. Sundar, S
    Treatment of visceral leishmaniasis
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY
    
    S. Sundar, "Treatment of visceral leishmaniasis", MED MICROBI, 190(1-2), 2001, pp. 89-92
12. Arana, B; Rizzo, N; Diaz, A
    Chemotherapy of cutaneous leishmaniasis: a review
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY
    
    B. Arana et al., "Chemotherapy of cutaneous leishmaniasis: a review", MED MICROBI, 190(1-2), 2001, pp. 93-95
13. Sereno, D; Holzmuller, P; Mangot, I; Cuny, G; Ouaissi, A; Lemesre, JL
    Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    D. Sereno et al., "Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes", ANTIM AG CH, 45(7), 2001, pp. 2064-2069
14. Sereno, D; Roy, G; Lemesre, JL; Papadopoulou, B; Ouellette, M
    DNA transformation of Leishmania infantum axenic amastigotes and their usein drug screening
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    D. Sereno et al., "DNA transformation of Leishmania infantum axenic amastigotes and their usein drug screening", ANTIM AG CH, 45(4), 2001, pp. 1168-1173
15. Thakur, CP; Dedet, JP; Narain, S; Pratlong, F
    Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    
    C.P. Thakur et al., "Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India", T RS TROP M, 95(2), 2001, pp. 187
16. Zijlstra, EE; El-Hassan, AM
    Leishmaniasis in Sudan 3. Visceral leishmaniasis
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    
    E.E. Zijlstra e A.M. El-Hassan, "Leishmaniasis in Sudan 3. Visceral leishmaniasis", T RS TROP M, 95, 2001, pp. S27-S58
17. Zijlstra, EE; El-Hassan, AM
    Leishmaniasis in Sudan 4. Post kala-azar dermal leishmaniasis
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    
    E.E. Zijlstra e A.M. El-Hassan, "Leishmaniasis in Sudan 4. Post kala-azar dermal leishmaniasis", T RS TROP M, 95, 2001, pp. S59-S76
18. Afrin, F; Dey, T; Anam, K; Ali, N
    Leishmanicidal activity of stearylamine-bearing liposomes in vitro
    JOURNAL OF PARASITOLOGY
    
    F. Afrin et al., "Leishmanicidal activity of stearylamine-bearing liposomes in vitro", J PARASITOL, 87(1), 2001, pp. 188-193
19. Shaked-Mishan, P; Ulrich, N; Ephros, M; Zilberstein, D
    Novel intracellular Sb-V reducing activity correlates with antimony susceptibility in Leishmania donovani
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    P. Shaked-Mishan et al., "Novel intracellular Sb-V reducing activity correlates with antimony susceptibility in Leishmania donovani", J BIOL CHEM, 276(6), 2001, pp. 3971-3976
20. Romero, GAS; Guerra, MVD; Paes, MG; Macedo, VD
    Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) Guyanensis in Brazil: Therapeutic response to meglumine antimoniate
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    
    G.A.S. Romero et al., "Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) Guyanensis in Brazil: Therapeutic response to meglumine antimoniate", AM J TROP M, 65(5), 2001, pp. 456-465
21. Arana, BA; Mendoza, CE; Rizzo, NR; Kroeger, A
    Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointmentin Guatemala
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    
    B.A. Arana et al., "Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointmentin Guatemala", AM J TROP M, 65(5), 2001, pp. 466-470
22. Sundar, S; Pai, K; Kumar, R; Pathak-Tripathi, K; Gam, AA; Ray, M; Kenney, RT
    Resistance to treatment in Kala-azar: Speciation of isolates from northeast India
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    
    S. Sundar et al., "Resistance to treatment in Kala-azar: Speciation of isolates from northeast India", AM J TROP M, 65(3), 2001, pp. 193-196
23. Palacios, R; Osorio, LE; Grajales, LF; Ochoa, MT
    Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    
    R. Palacios et al., "Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species", AM J TROP M, 64(3-4), 2001, pp. 187-193
24. Berhe, N; Hailu, A; Abraham, Y; Tadesse, Y; Breivik, K; Abebe, Y
    Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study
    ACTA TROPICA
    
    N. Berhe et al., "Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study", ACT TROP, 80(2), 2001, pp. 87-95
25. Veeken, H; Pecoul, B
    Drugs for 'neglected diseases': a bitter pill
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    H. Veeken e B. Pecoul, "Drugs for 'neglected diseases': a bitter pill", TR MED I H, 5(5), 2000, pp. 309-311
26. Veeken, H; Ritmeijer, K; Seaman, J; Davidson, R
    A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    H. Veeken et al., "A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan", TR MED I H, 5(5), 2000, pp. 312-317
27. Sundar, S; More, DK; Singh, MK; Singh, VP; Sharma, S; Makharia, A; Kumar, PCK; Murray, HW
    Failure of pentavalent antimony in visceral leishmaniasis in India: Reportfrom the center of the Indian epidemic
    CLINICAL INFECTIOUS DISEASES
    
    S. Sundar et al., "Failure of pentavalent antimony in visceral leishmaniasis in India: Reportfrom the center of the Indian epidemic", CLIN INF D, 31(4), 2000, pp. 1104-1107
28. Sundar, S; Makharia, A; More, DK; Agrawal, G; Voss, A; Fischer, C; Bachmann, P; Murray, HW
    Short-course of oral miltefosine for treatment of visceral leishmaniasis
    CLINICAL INFECTIOUS DISEASES
    
    S. Sundar et al., "Short-course of oral miltefosine for treatment of visceral leishmaniasis", CLIN INF D, 31(4), 2000, pp. 1110-1113
29. Goihman-Yahr, M
    Antihelminthic and antiparasitic drugs: Unapproved used or indications
    CLINICS IN DERMATOLOGY
    
    M. Goihman-Yahr, "Antihelminthic and antiparasitic drugs: Unapproved used or indications", CLIN DERMAT, 18(1), 2000, pp. 113-117
30. Hepburn, NC
    Cutaneous leishmaniasis
    CLINICAL AND EXPERIMENTAL DERMATOLOGY
    
    N.C. Hepburn, "Cutaneous leishmaniasis", CLIN EXP D, 25(5), 2000, pp. 363-370
31. Brecelj, M; Pikelj, F; Gubensek, F; Anderluh, G
    Polymerase chain reaction as a diagnostic tool for detecting Leishmania
    INFECTION
    
    M. Brecelj et al., "Polymerase chain reaction as a diagnostic tool for detecting Leishmania", INFECTION, 28(2), 2000, pp. 111-113
32. Hantson, P; Luyasu, S; Haufroid, V; Lambert, M
    Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy
    PHARMACOTHERAPY
    
    P. Hantson et al., "Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy", PHARMACOTHE, 20(9), 2000, pp. 1141-1143
33. Frezard, F; Michalick, MSM; Soares, CF; Demicheli, C
    Novel methods for the encapsulation of meglumine antimoniate into liposomes
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    F. Frezard et al., "Novel methods for the encapsulation of meglumine antimoniate into liposomes", BRAZ J MED, 33(7), 2000, pp. 841-846
34. Donald, PR; Sirgel, FA; Kanyok, TP; Danziger, LH; Venter, A; Botha, FJ; Parkin, DP; Seifart, HI; Van de Wal, BW; Martiz, JS; Mitchison, DA
    Early bactericidal activity of paromomycin (aminosidine) in patients with smear-positive pulmonary tuberculosis
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    P.R. Donald et al., "Early bactericidal activity of paromomycin (aminosidine) in patients with smear-positive pulmonary tuberculosis", ANTIM AG CH, 44(12), 2000, pp. 3285-3287
35. Llorente, S; Gimeno, L; Navarro, MJ; Moreno, S; Rodriguez-Girones, M
    Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials
    TRANSPLANTATION
    
    S. Llorente et al., "Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials", TRANSPLANT, 70(5), 2000, pp. 800-801
36. Boelaert, M; Criel, B; Leeuwenburg, J; Van Damme, W; Le Ray, D; Van der Stuyft, P
    Visceral leishmaniasis control: a public health perspective
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    
    M. Boelaert et al., "Visceral leishmaniasis control: a public health perspective", T RS TROP M, 94(5), 2000, pp. 465-471
37. Thakur, CP; Kanyok, TP; Pandey, AK; Sinha, GP; Zaniewski, AE; Houlihan, HH; Olliaro, P
    A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    
    C.P. Thakur et al., "A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis", T RS TROP M, 94(4), 2000, pp. 429-431
38. Thakur, CP; Kanyok, TP; Pandey, AK; Sinha, GP; Messick, C; Olliaro, P
    Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    
    C.P. Thakur et al., "Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study", T RS TROP M, 94(4), 2000, pp. 432-433
39. Sundar, S; Gupta, LB; Rastogi, V; Agrawal, G; Murray, HW
    Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    
    S. Sundar et al., "Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis", T RS TROP M, 94(2), 2000, pp. 200-204
40. Murray, HW; Delph-Etienne, S
    Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis
    INFECTION AND IMMUNITY
    
    H.W. Murray e S. Delph-Etienne, "Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis", INFEC IMMUN, 68(1), 2000, pp. 288-293
41. Alexander, J; Carter, KC; Al-Fasi, N; Satoskar, A; Brombacher, F
    Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    J. Alexander et al., "Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis", EUR J IMMUN, 30(10), 2000, pp. 2935-2943
42. Grech, V; Mizzi, J; Mangion, M; Vella, C
    Visceral leishmaniasis in Malta - an 18 year paediatric, population based study
    ARCHIVES OF DISEASE IN CHILDHOOD
    
    V. Grech et al., "Visceral leishmaniasis in Malta - an 18 year paediatric, population based study", ARCH DIS CH, 82(5), 2000, pp. 381-385
43. Dabiri, S; Meymandi, SS; Hayes, MM; Soleimani, F; Kharazmi, A
    Intralesional autotherapy of cutaneous leishmaniasis with buffy coat cells: cytological findings
    ACTA TROPICA
    
    S. Dabiri et al., "Intralesional autotherapy of cutaneous leishmaniasis with buffy coat cells: cytological findings", ACT TROP, 75(1), 2000, pp. 1-7
44. Seaton, RA; Morrison, J; Man, I; Watson, J; Nathwani, D
    Out-patient parenteral antimicrobial therapy - a viable option for the management of cutaneous leishmaniasis
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    R.A. Seaton et al., "Out-patient parenteral antimicrobial therapy - a viable option for the management of cutaneous leishmaniasis", QJM-MON J A, 92(11), 1999, pp. 659-667
45. Belloli, C; Crescenzo, G; Carli, S; Zaghini, A; Mengozzi, G; Bertini, S; Ormas, P
    Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs
    VETERINARY JOURNAL
    
    C. Belloli et al., "Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs", VET J, 157(3), 1999, pp. 315-321
46. Meyerhoff, A
    US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis
    CLINICAL INFECTIOUS DISEASES
    
    A. Meyerhoff, "US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis", CLIN INF D, 28(1), 1999, pp. 42-48
47. Bora, D
    Epidemiology of visceral leishmaniasis in India
    NATIONAL MEDICAL JOURNAL OF INDIA
    
    D. Bora, "Epidemiology of visceral leishmaniasis in India", NAT MED J I, 12(2), 1999, pp. 62-68
48. Loiseau, PM; Bories, C
    Recent strategies for the chemotherapy of visceral leishmaniasis
    CURRENT OPINION IN INFECTIOUS DISEASES
    
    P.M. Loiseau e C. Bories, "Recent strategies for the chemotherapy of visceral leishmaniasis", CURR OPIN I, 12(6), 1999, pp. 559-564
49. Foulquie, MR; Louassini, M; Castanys, S; Gamarro, F; Benitz, R; Adroher, FJ
    Different catalytic activities of hexokinase and phosphofructokinase in wild type and Glucantime-resistant Leishmania promastigotes appears not causatively related to resistance
    EUROPEAN JOURNAL OF PROTISTOLOGY
    
    M.R. Foulquie et al., "Different catalytic activities of hexokinase and phosphofructokinase in wild type and Glucantime-resistant Leishmania promastigotes appears not causatively related to resistance", EUR J PROT, 35(3), 1999, pp. 338-341
50. Minodier, P; Faraut-Gambarelli, E; Piarroux, R; Gire, C; Garnier, JM; Dumon, H
    Visceral leishmaniasis treatment in children.
    ARCHIVES DE PEDIATRIE
    
    P. Minodier et al., "Visceral leishmaniasis treatment in children.", ARCH PED, 6(1), 1999, pp. 59-66
51. Gangneux, JP
    Treatment of visceral leishmaniasis: recent developments
    PRESSE MEDICALE
    
    J.P. Gangneux, "Treatment of visceral leishmaniasis: recent developments", PRESSE MED, 28(37), 1999, pp. 2057-2066
52. Moskowitz, PF; Kurban, AK
    Treatment of cutaneous leishmaniasis: Retrospectives and advances for the 21st century
    CLINICS IN DERMATOLOGY
    
    P.F. Moskowitz e A.K. Kurban, "Treatment of cutaneous leishmaniasis: Retrospectives and advances for the 21st century", CLIN DERMAT, 17(3), 1999, pp. 305-315
53. Kenner, JR; Aronson, NE; Benson, PM
    The United States military and leishmaniasis
    DERMATOLOGIC CLINICS
    
    J.R. Kenner et al., "The United States military and leishmaniasis", DERM CLIN, 17(1), 1999, pp. 77
54. Segura, I; Garcia-Bolao, I
    Meglumine antimoniate, amiodarone and torsades de pointes: a case report
    RESUSCITATION
    
    I. Segura e I. Garcia-Bolao, "Meglumine antimoniate, amiodarone and torsades de pointes: a case report", RESUSCITAT, 42(1), 1999, pp. 65-68
55. Laguna, F; Lopez-Velez, R; Pulido, F; Salas, A; Torre-Cisneros, J; Torres, E; Medrano, FJ; Sanz, J; Pico, G; Gomez-Rodrigo, J; Pasquau, J; Alvar, J
    Treatment of visceral leishmaniasis in HIV-infected patients: a randomizedtrial comparing meglumine antimoniate with amphotericin B
    AIDS
    
    F. Laguna et al., "Treatment of visceral leishmaniasis in HIV-infected patients: a randomizedtrial comparing meglumine antimoniate with amphotericin B", AIDS, 13(9), 1999, pp. 1063-1069
56. Davidson, RN
    Visceral leishmaniasis in clinical practice
    JOURNAL OF INFECTION
    
    R.N. Davidson, "Visceral leishmaniasis in clinical practice", J INFECTION, 39(2), 1999, pp. 112-116
57. Ribeiro, ALP; Drummond, JB; Volpini, AC; Andrade, AC; Passos, VMA
    Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    A.L.P. Ribeiro et al., "Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine", BRAZ J MED, 32(3), 1999, pp. 297-301
58. Ephros, M; Bitnun, A; Shaked, P; Waldman, E; Zilberstein, D
    Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    M. Ephros et al., "Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes", ANTIM AG CH, 43(2), 1999, pp. 278-282
59. Al-Abdely, HM; Graybill, JR; Loebenberg, D; Melby, PC
    Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    H.M. Al-Abdely et al., "Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases", ANTIM AG CH, 43(12), 1999, pp. 2910-2914
60. Gangneux, JP; Dullin, M; Sulahian, A; Garin, YJF; Derouin, F
    Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    J.P. Gangneux et al., "Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum", ANTIM AG CH, 43(1), 1999, pp. 172-174
61. Boelaert, M; Lynen, L; Desjeux, P; Van der Stuyft, P
    Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis
    BULLETIN OF THE WORLD HEALTH ORGANIZATION
    
    M. Boelaert et al., "Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis", B WHO, 77(8), 1999, pp. 667-674
62. Snawder, JE; Tirmenstein, MA; Mathias, PI; Toraason, M
    Induction of stress proteins in rat cardiac myocytes by antimony
    TOXICOLOGY AND APPLIED PHARMACOLOGY
    
    J.E. Snawder et al., "Induction of stress proteins in rat cardiac myocytes by antimony", TOX APPL PH, 159(2), 1999, pp. 91-97
63. Thakur, CP; Singh, RK; Hassan, SM; Kumar, R; Narain, S; Kumar, A
    Amphotericin B deoxycholate treatment of visceral leishmaniasis with newermodes of administration and precautions: a study of 938 cases
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    
    C.P. Thakur et al., "Amphotericin B deoxycholate treatment of visceral leishmaniasis with newermodes of administration and precautions: a study of 938 cases", T RS TROP M, 93(3), 1999, pp. 319-323
64. Smego, RA; Castiglia, M; Asperilla, MO
    Lymphocutaneous syndrome - A review of non-sporothrix causes
    MEDICINE
    
    R.A. Smego et al., "Lymphocutaneous syndrome - A review of non-sporothrix causes", MEDICINE, 78(1), 1999, pp. 38-63
65. Grogl, M; Schuster, BG; Ellis, WY; Berman, JD
    Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamicin
    JOURNAL OF PARASITOLOGY
    
    M. Grogl et al., "Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamicin", J PARASITOL, 85(2), 1999, pp. 354-359
66. Robledo, SM; Valencia, AZ; Saravia, NG
    Sensitivity to Glucantime (R) of Leishmania viannia isolated from patientsprior to treatment
    JOURNAL OF PARASITOLOGY
    
    S.M. Robledo et al., "Sensitivity to Glucantime (R) of Leishmania viannia isolated from patientsprior to treatment", J PARASITOL, 85(2), 1999, pp. 360-366
67. Lira, R; Sundar, S; Makharia, A; Kenney, R; Gam, A; Saraiva, E; Sacks, D
    Evidence that the high incidence of treatment failures in Indian kala-azaris due to the emergence of antimony-resistant strains of Leishmania donovani
    JOURNAL OF INFECTIOUS DISEASES
    
    R. Lira et al., "Evidence that the high incidence of treatment failures in Indian kala-azaris due to the emergence of antimony-resistant strains of Leishmania donovani", J INFEC DIS, 180(2), 1999, pp. 564-567
68. Mujtaba, G; Khalid, M
    Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis
    INTERNATIONAL JOURNAL OF DERMATOLOGY
    
    G. Mujtaba e M. Khalid, "Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis", INT J DERM, 38(8), 1999, pp. 607-609
69. Berman, J; Dietze, R
    Treatment of visceral leishmaniasis with Amphotericin B Colloidal Dispersion
    CHEMOTHERAPY
    
    J. Berman e R. Dietze, "Treatment of visceral leishmaniasis with Amphotericin B Colloidal Dispersion", CHEMOTHERA, 45, 1999, pp. 54-66
70. Everlien, H; Hockertz, S
    Combined liposomal immuno- and chemotherapy of visceral leishmaniasis
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    H. Everlien e S. Hockertz, "Combined liposomal immuno- and chemotherapy of visceral leishmaniasis", ARZNEI-FOR, 49(11), 1999, pp. 954-961
71. Vargas-Gonzalez, A; Canto-Lara, SB; Damian-Centeno, AG; Andrade-Narvaez, FJ
    Response of cutaneous leishmaniasis (Chiclero's ulcer) to treatment with meglumine antimoniate in southeast Mexico
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    
    A. Vargas-Gonzalez et al., "Response of cutaneous leishmaniasis (Chiclero's ulcer) to treatment with meglumine antimoniate in southeast Mexico", AM J TROP M, 61(6), 1999, pp. 960-963
72. Delgado, J; Macias, J; Pineda, JA; Corzo, JE; Gonzalez-Moreno, MP; De la Rosa, R; Sanchez-Quijano, A; Leal, M; Lissen, E
    High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    
    J. Delgado et al., "High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients", AM J TROP M, 61(5), 1999, pp. 766-769
73. Dassopoulos, T; Ehrenpreis, ED
    Acute pancreatitis in human immunodeficiency virus-infected patients: A review
    AMERICAN JOURNAL OF MEDICINE
    
    T. Dassopoulos e E.D. Ehrenpreis, "Acute pancreatitis in human immunodeficiency virus-infected patients: A review", AM J MED, 107(1), 1999, pp. 78-84
74. Burbach, G; May, J; Harms, G; Bienzle, U
    Leishmaniasis
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    G. Burbach et al., "Leishmaniasis", DEUT MED WO, 124(4), 1999, pp. 88-93
75. LOCKWOOD DNJ
    SOME GOOD-NEWS FOR TREATMENT OF VISCERAL LEISHMANIASIS IN BIHAR - COMMENTARY
    BMJ. British medical journal
    
    D.N.J. Lockwood, "SOME GOOD-NEWS FOR TREATMENT OF VISCERAL LEISHMANIASIS IN BIHAR - COMMENTARY", BMJ. British medical journal, 316(7139), 1998, pp. 1205-1205
76. MOREIRA ESA; ANACLETO C; PETRILLOPEIXOTO MD
    EFFECT OF GLUCANTIME ON FIELD AND PATIENT ISOLATES OF NEW-WORLD LEISHMANIA - USE OF GROWTH-PARAMETERS OF PROMASTIGOTES TO ASSESS ANTIMONY SUSCEPTIBILITY
    Parasitology research
    
    E.S.A. Moreira et al., "EFFECT OF GLUCANTIME ON FIELD AND PATIENT ISOLATES OF NEW-WORLD LEISHMANIA - USE OF GROWTH-PARAMETERS OF PROMASTIGOTES TO ASSESS ANTIMONY SUSCEPTIBILITY", Parasitology research, 84(9), 1998, pp. 720-726
77. UCHEGBU IF; VYAS SP
    NONIONIC SURFACTANT BASED VESICLES (NIOSOMES) IN DRUG-DELIVERY
    International journal of pharmaceutics
    
    I.F. Uchegbu e S.P. Vyas, "NONIONIC SURFACTANT BASED VESICLES (NIOSOMES) IN DRUG-DELIVERY", International journal of pharmaceutics, 172(1-2), 1998, pp. 33-70
78. BALANAFOUCE R; REGUERA RM; CUBRIA JC; ORDONEZ D
    THE PHARMACOLOGY OF LEISHMANIASIS
    General pharmacology
    
    R. Balanafouce et al., "THE PHARMACOLOGY OF LEISHMANIASIS", General pharmacology, 30(4), 1998, pp. 435-443
79. VALLADARES JE; RIERA C; ALBEROLA J; GALLEGO M; PORTUS M; CRISTOFOL C; FRANQUELO C; ARBOIX M
    PHARMACOKINETICS OF MEGLUMINE ANTIMONIATE AFTER ADMINISTRATION OF A MULTIPLE-DOSE IN DOGS EXPERIMENTALLY INFECTED WITH LEISHMANIA-INFANTUM
    Veterinary parasitology
    
    J.E. Valladares et al., "PHARMACOKINETICS OF MEGLUMINE ANTIMONIATE AFTER ADMINISTRATION OF A MULTIPLE-DOSE IN DOGS EXPERIMENTALLY INFECTED WITH LEISHMANIA-INFANTUM", Veterinary parasitology, 75(1), 1998, pp. 33-40
80. Alkhawajah, A
    Recent trends in the treatment of cutaneous leishmaniasis
    ANNALS OF SAUDI MEDICINE
    
    A. Alkhawajah, "Recent trends in the treatment of cutaneous leishmaniasis", ANN SAUDI M, 18(5), 1998, pp. 412-416
81. REYMOND JM; DESMEULES J
    SODIUM STIBOGLUCONATE (PENTOSTAN) OVERDOSE IN A PATIENT WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    Therapeutic drug monitoring
    
    J.M. Reymond e J. Desmeules, "SODIUM STIBOGLUCONATE (PENTOSTAN) OVERDOSE IN A PATIENT WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME", Therapeutic drug monitoring, 20(6), 1998, pp. 714-716
82. LUCUMI A; ROBLEDO S; GAMA V; SARAVIA NG
    SENSITIVITY OF LEISHMANIA-VIANNIA-PANAMENSIS TO PENTAVALENT ANTIMONY IS CORRELATED WITH THE FORMATION OF CLEAVABLE DNA-PROTEIN COMPLEXES
    Antimicrobial agents and chemotherapy
    
    A. Lucumi et al., "SENSITIVITY OF LEISHMANIA-VIANNIA-PANAMENSIS TO PENTAVALENT ANTIMONY IS CORRELATED WITH THE FORMATION OF CLEAVABLE DNA-PROTEIN COMPLEXES", Antimicrobial agents and chemotherapy, 42(8), 1998, pp. 1990-1995
83. LEFICHOUX Y; ROUSSEAU D; FERRUA B; RUETTE S; LELIEVRE A; GROUSSON D; KUBAR J
    SHORT-TERM AND LONG-TERM EFFICACY OF HEXADECYLPHOSPHOCHOLINE AGAINST ESTABLISHED LEISHMANIA-INFANTUM INFECTION IN BALB C MICE/
    Antimicrobial agents and chemotherapy
    
    Y. Lefichoux et al., "SHORT-TERM AND LONG-TERM EFFICACY OF HEXADECYLPHOSPHOCHOLINE AGAINST ESTABLISHED LEISHMANIA-INFANTUM INFECTION IN BALB C MICE/", Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 654-658
84. Sereno, D; Cavaleyra, M; Zemzoumi, K; Maquaire, S; Ouaissi, A; Lemesre, JL
    Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    D. Sereno et al., "Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action", ANTIM AG CH, 42(12), 1998, pp. 3097-3102
85. BERMAN JD; BADARO R; THAKUR CP; WASUNNA KM; BEHBEHANI K; DAVIDSON R; KUZOE F; PANG L; WEERASURIYA K; BRYCESON ADM
    EFFICACY AND SAFETY OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) FOR VISCERAL LEISHMANIASIS IN ENDEMIC DEVELOPING-COUNTRIES
    Bulletin of the World Health Organization
    
    J.D. Berman et al., "EFFICACY AND SAFETY OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) FOR VISCERAL LEISHMANIASIS IN ENDEMIC DEVELOPING-COUNTRIES", Bulletin of the World Health Organization, 76(1), 1998, pp. 25-32
86. BERENGUER J; GOMEZCAMPDERA F; PADILLA B; RODRIGUEZFERRERO H; ANAYA F; MORENO S; VALDERRABANO F
    VISCERAL LEISHMANIASIS (KALA-AZAR) IN TRANSPLANT RECIPIENTS - CASE-REPORT AND REVIEW
    Transplantation
    
    J. Berenguer et al., "VISCERAL LEISHMANIASIS (KALA-AZAR) IN TRANSPLANT RECIPIENTS - CASE-REPORT AND REVIEW", Transplantation, 65(10), 1998, pp. 1401-1404
87. OSMAN OF; OSKAM L; ZIJLSTRA EE; ELHASSAN AM; ELNAEIM DA; KAGER PA
    USE OF THE POLYMERASE-CHAIN-REACTION TO ASSESS THE SUCCESS OF VISCERAL LEISHMANIASIS TREATMENT
    Transactions of the Royal Society of Tropical Medicine and Hygiene
    
    O.F. Osman et al., "USE OF THE POLYMERASE-CHAIN-REACTION TO ASSESS THE SUCCESS OF VISCERAL LEISHMANIASIS TREATMENT", Transactions of the Royal Society of Tropical Medicine and Hygiene, 92(4), 1998, pp. 397-400
88. Martin, S; Gambel, J; Jackson, J; Aronson, N; Gupta, R; Rowton, E; Perich, M; McEvoy, P; Berman, J; Magill, A; Hoke, C
    Leishmaniasis in the United States Military
    MILITARY MEDICINE
    
    S. Martin et al., "Leishmaniasis in the United States Military", MILIT MED, 163(12), 1998, pp. 801-807
89. VAZQUEZ ST; SALAZAR MAG; MARTIN MJJ; MARTINEZ JL
    TORSADE-DE-POINTES SECONDARY TO TREATMENT WITH PENTAVALENT ANTIMONIALDRUGS
    Medicina Clinica
    
    S.T. Vazquez et al., "TORSADE-DE-POINTES SECONDARY TO TREATMENT WITH PENTAVALENT ANTIMONIALDRUGS", Medicina Clinica, 110(18), 1998, pp. 717-717
90. MITTAL N; GUPTA N; SAKSENA S; GOYAL N; ROY U; RASTOGI AK
    PROTECTIVE EFFECT OF PICROLIV FROM PICRORHIZA-KURROA AGAINST LEISHMANIA-DONOVANI INFECTIONS IN MESOCRICETUS-AURATUS
    Life sciences (1973)
    
    N. Mittal et al., "PROTECTIVE EFFECT OF PICROLIV FROM PICRORHIZA-KURROA AGAINST LEISHMANIA-DONOVANI INFECTIONS IN MESOCRICETUS-AURATUS", Life sciences (1973), 63(20), 1998, pp. 1823-1834
91. Williams, D; Mullen, AB; Baillie, AJ; Carter, KC
    Comparison of the efficacy of free and non-ionic-surfactant vesicular formulations of paromomycin in a murine model of visceral leishmaniasis
    JOURNAL OF PHARMACY AND PHARMACOLOGY
    
    D. Williams et al., "Comparison of the efficacy of free and non-ionic-surfactant vesicular formulations of paromomycin in a murine model of visceral leishmaniasis", J PHARM PHA, 50(12), 1998, pp. 1351-1356
92. Davidson, RN
    Practical guide for the treatment of leishmaniasis
    DRUGS
    
    R.N. Davidson, "Practical guide for the treatment of leishmaniasis", DRUGS, 56(6), 1998, pp. 1009-1018
93. SMITH HR; CONNOR MP; BEER TW; ASHTON RE
    THE USE OF POLYMERASE-CHAIN-REACTION IN NEW-WORLD CUTANEOUS LEISHMANIASIS
    British journal of dermatology
    
    H.R. Smith et al., "THE USE OF POLYMERASE-CHAIN-REACTION IN NEW-WORLD CUTANEOUS LEISHMANIASIS", British journal of dermatology, 139(3), 1998, pp. 539-540
94. ASTE N; PAU M; FERRELI C; BIGGIO P
    INTRALESIONAL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH MEGLUMINE ANTIMONIATE
    British journal of dermatology
    
    N. Aste et al., "INTRALESIONAL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH MEGLUMINE ANTIMONIATE", British journal of dermatology, 138(2), 1998, pp. 370-371
95. BEUGIN S; EDWARDS K; KARLSSON G; OLLIVON M; LESIEUR S
    NEW STERICALLY STABILIZED VESICLES BASED ON NONIONIC SURFACTANT, CHOLESTEROL, AND POLY(ETHYLENE GLYCOL)-CHOLESTEROL CONJUGATES
    Biophysical journal
    
    S. Beugin et al., "NEW STERICALLY STABILIZED VESICLES BASED ON NONIONIC SURFACTANT, CHOLESTEROL, AND POLY(ETHYLENE GLYCOL)-CHOLESTEROL CONJUGATES", Biophysical journal, 74(6), 1998, pp. 3198-3210
96. SUNDAR S; GOYAL AK; MORE DK; SINGH MK; MURRAY HW
    TREATMENT OF ANTIMONY-UNRESPONSIVE INDIAN VISCERAL LEISHMANIASIS WITHULTRA-SHORT COURSES OF AMPHOTERICIN-B-LIPID COMPLEX
    Annals of tropical medicine and parasitology
    
    S. Sundar et al., "TREATMENT OF ANTIMONY-UNRESPONSIVE INDIAN VISCERAL LEISHMANIASIS WITHULTRA-SHORT COURSES OF AMPHOTERICIN-B-LIPID COMPLEX", Annals of tropical medicine and parasitology, 92(7), 1998, pp. 755-764
97. OLIVA G; GRADONI L; CORTESE L; ORSINI S; CIARAMELLA P; SCALONE A; DELUNA R; PERSECHINO A
    COMPARATIVE EFFICACY OF MEGLUMINE ANTIMONIATE AND AMINOSIDINE SULFATE, ALONE OR IN COMBINATION, IN CANINE LEISHMANIASIS
    Annals of tropical medicine and parasitology
    
    G. Oliva et al., "COMPARATIVE EFFICACY OF MEGLUMINE ANTIMONIATE AND AMINOSIDINE SULFATE, ALONE OR IN COMBINATION, IN CANINE LEISHMANIASIS", Annals of tropical medicine and parasitology, 92(2), 1998, pp. 165-171
98. SUNDAR S; SINHA PR; AGRAWAL NK; SRIVASTAVA R; RAINEY PM; BERMAN JD; MURRAY HW; SINGH VP
    A CLUSTER OF CASES OF SEVERE CARDIOTOXICITY AMONG KALA-AZAR PATIENTS TREATED WITH A HIGH-OSMOLARITY LOT OF SODIUM ANTIMONY GLUCONATE
    The American journal of tropical medicine and hygiene
    
    S. Sundar et al., "A CLUSTER OF CASES OF SEVERE CARDIOTOXICITY AMONG KALA-AZAR PATIENTS TREATED WITH A HIGH-OSMOLARITY LOT OF SODIUM ANTIMONY GLUCONATE", The American journal of tropical medicine and hygiene, 59(1), 1998, pp. 139-143
99. VEXENAT JA; OLLIARO PL; DECASTRO JAF; CAVALCANTE R; CAMPOS JHF; TAVARES JP; MILES MA
    CLINICAL RECOVERY AND LIMITED CURE IN CANINE VISCERAL LEISHMANIASIS TREATED WITH AMINOSIDINE (PAROMOMYCIN)
    The American journal of tropical medicine and hygiene
    
    J.A. Vexenat et al., "CLINICAL RECOVERY AND LIMITED CURE IN CANINE VISCERAL LEISHMANIASIS TREATED WITH AMINOSIDINE (PAROMOMYCIN)", The American journal of tropical medicine and hygiene, 58(4), 1998, pp. 448-453
100. Hendrickx, EP; Agudelo, SD; Munoz, DL; Puerta, JA; Bernal, IDV
     Lack of efficacy of mefloquine in the treatment of new world cutaneous leishmaniasis in Colombia
     AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
     
     E.P. Hendrickx et al., "Lack of efficacy of mefloquine in the treatment of new world cutaneous leishmaniasis in Colombia", AM J TROP M, 59(6), 1998, pp. 889-892